Catch up on the top pharma news stories of July in EMJ GOLD’s monthly round-up, including insights on pharma’s use of social media.

The weight loss drug reduces the risk of hospitalisation, death and more for adults with obesity and a common form of heart failure.

BMS has been a vocal opponent of drug price negotiations under the US’ Inflation Reduction Act, but a price preview may have allayed fears.

Researchers and pharmaceutical companies could get wider access to NHS data for the first time under new Labour plans.

With avian influenza posing an ongoing public health threat, a new initiative has been launched to better prepare low- and middle-income countries.

Pfizer’s new gene therapy for haemophilia A has been found to significantly reduce the number of annual bleeding events in patients with the disorder.

Agilent Technologies has announced the acquisition of contract drug manufacturing company Biovectra to expand its offerings to biotech companies and medical researchers.

A 14-year-old boy’s death from Nipah virus in India, highlights the urgent need for medical interventions against this deadly disease.